Mirabegron Tablet, Film Coated, Extended Release
NDC 68180-152
Product Information
Mirabegron is a ANDA-approved product labeled by Lupin Pharmaceuticals, Inc.. This medication is used to treat overactive bladder. It is supplied as a white tablet, film coated, extended release for oral administration. This product entry covers the primary NDC 68180-152 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
YELLOW (C48330 - PALE-YELLOW)
LU;M25
LU;M50
Code Structure Chart
Product Details
What is NDC 68180-152?
What are the uses of this product?
What are Active Ingredients of this product?
- MIRABEGRON 50 mg/1 - a beta3-adrenergic receptor agonist; structure in first source
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MIRABEGRON (UNII: MVR3JL3B2V)
- MIRABEGRON (UNII: MVR3JL3B2V) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
- HYDROXYPROPYL CELLULOSE (1600000 WAMW) (UNII: RFW2ET671P)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POLYETHYLENE GLYCOL 6000 (UNII: 30IQX730WE)
- POLYETHYLENE OXIDE 1000000 (UNII: HZ58M6D839)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TRIACETIN (UNII: XHX3C3X673)
- D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1300791 - mirabegron 25 MG 24HR Extended Release Oral Tablet
- RxCUI: 1300791 - 24 HR mirabegron 25 MG Extended Release Oral Tablet
- RxCUI: 1300791 - mirabegron 25 MG 24 HR Release Tablet
- RxCUI: 1300801 - mirabegron 50 MG 24HR Extended Release Oral Tablet
- RxCUI: 1300801 - 24 HR mirabegron 50 MG Extended Release Oral Tablet
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.
Patient Education
Mirabegron
Mirabegron is used alone or in combination with solifenacin (Vesicare) to treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination) in adults. It is also used to treat neurogenic detrusor overactivity (a bladder control condition caused by brain, spinal cord or nerve problem) in children 3 years of age and older. Mirabegron is in a class of medications called beta-3 adrenergic agonists. It works by relaxing the bladder muscles to prevent urgent, frequent, or uncontrolled urination.
[Learn More]
* Please review the full disclaimer at the bottom of this page.